Camber Spine reaches $1M milestone with cervical interbody: 5 details

Mackenzie Garrity -   Print  |

Camber Spine has generated $1 million from the Spira-C interbody device within six months of its commercial launch.

Here are five details:

1. The Spira-C features a large opening for significant graft packing. Its proprietary Surface By Design roughened titanium surface is designed to promote mechanical fusion bone in-growth.

2. Camber Spine designed the cervical interbody device to allow newly-forming bone to grow on and through the multiple roughened titanium arches to achieve maximum stability and completed endplate-to-endplate arthrodesis.

3. The company has various studies underway evaluating Spira-C. A team at Camber Spine is working with researchers and engineers to collaborate on the design and features of the device.

4. Ira Garonzik, MD, was among the first surgeons to begin using the Spira-C. "In review of our first 50 levels using Spira-C, my partner James Conway, MD, PhD, and I have noticed excellent fusion rates, maintenance of lordotic correction and a decreased evidence of graft subsidence compared to previously used PEEK and allograft spacers."

5. Drs. Garonzik and Conway attributed the positive fusion rates to Spira-C's open architecture concept, which is designed to distribute load across the vertebral endplates and facilitate fusion.

More articles on surface technology:
DJO's TKA design improves patient satisfaction
Medacta launches MySpine MC: 3 things to know
Skeletal deformity company raises $5.8M: 4 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers